Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...

Introduction to Electrolytes

Introduction to Electrolytes

In humans, electrolytes play a vital role in various physiological processes. Balancing electrolyte levels is essential for normal body functions; their imbalance can be life-threatening. The major electrolytes include sodium, potassium, chloride, calcium, phosphate, and bicarbonate. They are primarily involved in physiological processes, such as nerve signal transmission, membrane trafficking, muscle contraction, buffering body fluids, and balancing water levels in the body.
Role of Sodium
One...

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

Chronic Kidney Disease IV: Nursing Management

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...

Role of Vitamins in Maintaining Bone Health

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sub-Antarctic subtidal and intertidal macroalgae in rocky ecosystems of Inútil Bay, Tierra del Fuego in Southern Patagonia.

Biodiversity data journal·2026

Same author

Corrigendum to "Ceftriaxone administration reduces vascular calcification associated with experimental models of chronic kidney disease." [Biomed. Pharmacother. 197 (2026), 119131].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Same author

Ceftriaxone administration reduces vascular calcification associated with experimental models of chronic kidney disease.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Same author

Probiotic Supplementation in Chronic Kidney Disease: Outcomes on Uremic Toxins, Inflammation, and Vascular Calcification from Experimental and Clinical Models.

Toxins·2026

Same author

The Phosphate/Urea Nitrogen Ratio in Urine-A Method to Assess the Relative Intake of Inorganic Phosphate.

Nutrients·2025

Same author

New biomarkers of inflammation associated with haemodialysis.

Clinical kidney journal·2025

Search research articles

Related Experiment Video

Updated: May 11, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Magnesium - its role in CKD.

Angel L M de Francisco¹, Mariano Rodríguez

¹Servicio de Nefrología, Hospital Universitario Marqués de Valdecilla, Santander, Spain. angelmartindefrancisco@gmail.com

Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia

|May 4, 2013

Summary

Magnesium compounds show promise for treating hyperphosphatemia in chronic kidney disease (CKD). Further research is needed to clarify magnesium

Area of Science:

Nephrology
Biochemistry
Clinical Medicine

Background:

Oral magnesium compounds are potential treatments for hyperphosphatemia in chronic kidney disease (CKD).
The precise role of magnesium in CKD patients requires further elucidation in clinical practice.
Hypomagnesemia is prevalent, particularly in intensive care units, and often undetected, increasing risks for diabetes, hypertension, and atherosclerosis.

Purpose of the Study:

To provide a practical overview of magnesium's physiological role in general and specifically in CKD patients.
To re-examine the significance of magnesium in managing CKD, considering recent findings on magnesium-based phosphate binders.

Main Methods:

Literature review and synthesis of existing knowledge on magnesium's physiological effects.

More Related Videos

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium

Published on: September 1, 2015

Related Experiment Videos

Last Updated: May 11, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium

Published on: September 1, 2015

Analysis of studies concerning magnesium levels, phosphate binding, and clinical outcomes in CKD patients.

Evaluation of recent clinical trial data comparing magnesium-based binders with conventional treatments.

Main Results:

Moderate hypermagnesemia may offer benefits regarding vascular calcification and mortality in CKD patients.
Low magnesium levels are linked to low bone mass, osteoporosis, and vascular calcification.
A magnesium carbonate and calcium acetate combination showed efficacy and tolerability comparable to sevelamer hydrochloride.

Conclusions:

Magnesium plays a complex role in CKD, with potential benefits at moderate levels but controversial effects on bone health.
Dialysate magnesium concentration significantly influences serum levels in dialysis patients.
Further randomized controlled trials are necessary to confirm magnesium's potential to delay arterial calcification and improve survival in dialysis patients.